RhoA/Rho-kinase pathway:: much more than just a modulation of vascular tone.: Evidence from studies in humans

被引:100
作者
Calo, Lorenzo A. [1 ]
Pessina, Achille C. [1 ]
机构
[1] Univ Padua, Dept Clin & Expt Med, I-35128 Padua, Italy
关键词
atherogenesis; Bartter's/Gitelman's syndromes; cardiovascular remodeling; hypertension; inflammation; insulin resistance; nitric oxide; RhoA; Rho-kinase;
D O I
10.1097/HJH.0b013e328010d4d2
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
RhoA/Rho-kinase signaling and its relationship/balance with the nitric oxide level, angiotensin 11 and vasopressors for cardiovascular pathophysiology is of increasing importance, and its involvement goes far beyond blood pressure regulation. The deep involvement of this pathway in cardiovascular biology is now known to include a wide spectrum of conditions relating to the long-term complications of hypertension, and in general of cardiovascular pathophysiology, such as changes in cardiovascular structure (remodeling) and the induction of atherosclerosis, involvement in the pathophysiological relationships between inflammation and hypertension, and in those between hypertension, glucose metabolism and insulin resistance. Studies from our laboratory have made an important contribution to the understanding of the cellular and molecular mechanisms mediated by the RhoA/Rho-kinase pathway, which include all the aspects of cardiovascular pathophysiology in which this pathway plays a role. In addition, if it is considered that our contribution to the clarification of these mechanisms only comes from studies in humans, their impact on the scenario of the RhoA/Rho-kinase pathway's biology, essentially supported by studies 'in vitro' or in animal models, is immediate. This review examines all the aspects of RhoA/Rho-kinase signaling in the light of the available data, and gives an updated and useful overall picture of its involvement in cardiovascular pathophysiology. J Hypertens 25:259-264 (c) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 52 条
[1]  
ASANO T, 1987, J PHARMACOL EXP THER, V241, P1033
[2]   Monocyte NADPH oxidase subunit p22phox and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients:: Relationship with oxidative stress [J].
Avogaro, A ;
Pagnin, E ;
Calò, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1753-1759
[3]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[4]  
Calò L, 1999, CLIN NEPHROL, V51, P12
[5]   Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome) [J].
Calò, L ;
Sartore, G ;
Bassi, A ;
Basso, C ;
Bertocco, S ;
Marin, R ;
Zambon, S ;
Cantaro, S ;
D'Angelo, A ;
Davis, PA ;
Manzato, E ;
Crepaldi, G .
JOURNAL OF HYPERTENSION, 1998, 16 (07) :1001-1008
[6]   Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes:: Relationship with vascular hyporeactivity [J].
Calò, L ;
Davis, PA ;
Semplicini, A .
KIDNEY INTERNATIONAL, 2002, 61 (01) :353-354
[7]   Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes [J].
Calò, L ;
Ceolotto, G ;
Milani, M ;
Pagnin, E ;
van den Heuvel, LP ;
Sartori, M ;
Davis, PA ;
Costa, R ;
Semplicini, A .
KIDNEY INTERNATIONAL, 2001, 60 (03) :882-889
[8]  
CALO L, 1996, AM J KIDNEY DIS, V27, P874
[9]   Vascular tone control in humans:: Insights from studies in Bartter's/Gitelman's syndromes [J].
Calò, LA .
KIDNEY INTERNATIONAL, 2006, 69 (06) :963-966
[10]   Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome.: A role in the control of vascular tone and implication for hypertension. [J].
Calò, LA ;
Pagnin, E ;
Davis, PA ;
Sartori, M ;
Ceolotto, G ;
Pessina, AC ;
Semplicini, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :4153-4157